Moreover, market based on disease type includes gastro-esophageal reflux disorder
(gerd), inflammatory bowel disease, and other, whereas, end user segment comprises
hospital pharmacies, retail pharmacies and other.
Make an Enquiry:-
https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/768
Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America,
Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market
size for each geography is provided over the period of 2017 – 2023.
North America is the largest market for gastrointestinal drugs market, by having over
40% of global markets shares in 2016. The region anticipated to continue its dominance
throughout the forecasted period. Moreover, U.S. and Mexico collectively drives the
North American gastrointestinal market by contributing in the majority regional growth.
Rising geriatric population base in the North America is the key driving factor in this
region along with consumer friendly reimbursement policies for the treatment of
chronic disease. Europe is the second largest market followed by Asia Pacific is at third